Historical record - last NADAC effective date: 6/19/2019
Product Information
ERYTHROMYCIN DR 250 MG CAP is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $4.8072 per EA under NDC 24338012013. Its NADAC has been published 342 times since Nov 28, 2013.
FDA first approved this application on Dec 22, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Arbor Pharmaceuticals, Inc.NDC
24338012013
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
6/19/2019
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062746FDA Approved
12/22/1986
TE Code
AB
On Market Since
1/10/2012
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 250 MG CAP has been published 342 times since Nov 28, 2013, and over the history we have for it it has risen 53.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8072 per EA |
|---|---|
| All-time high | $5.5413 (Apr 12, 2017) |
| All-time low | $2.7894 (Aug 19, 2015) |
| Median price | $4.4728 |
| Average price | $4.3318 |
| Largest weekly change | +40.4% (Oct 21, 2015) |
| Weeks tracked | 342 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+53.6%
Last surveyed Jun 10, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Erythromycin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 250 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 250 MG CAP, manufactured by Arbor Pharmaceuticals, Inc., is $4.8072 per EA (NDC 24338012013), effective Jun 10, 2020.
How has the price of ERYTHROMYCIN DR 250 MG CAP changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 250 MG CAP has risen 53.6%. It has been tracked across 342 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 250 MG CAP?
Since Nov 28, 2013, the NADAC for ERYTHROMYCIN DR 250 MG CAP has ranged from a low of $2.7894 (Aug 19, 2015) to a high of $5.5413 (Apr 12, 2017), with a median of $4.4728 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 250 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of ERYTHROMYCIN DR 250 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ERYTHROMYCIN DR 250 MG CAP?
ERYTHROMYCIN DR 250 MG CAP (NDC 24338012013) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.